| For: | Stanilov N, Grigorova A, Velikova T, Stanilova SA. Genetic variation of TGF-ΒR2 as a protective genotype for the development of colorectal cancer in men. World J Gastrointest Oncol 2021; 13(11): 1766-1780 [PMID: 34853649 DOI: 10.4251/wjgo.v13.i11.1766] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i11/1766.htm |
| Number | Citing Articles |
| 1 |
Huang Chao, Haosheng Liu, Weizeng Shen. Clinical importance of the interactions between the TGF-β1/SMAD and NF-κB pathways in colorectal cancer and the study of the synergistic regulatory mechanism of the STAT3-mediated pathway. Anti-Cancer Drugs 2026; 37(3): 204 doi: 10.1097/CAD.0000000000001802
|
| 2 |
Guolei Li, Xuhua Hu, Guiying Wang, Cuizhi Geng. Methylation detection of circulating tumor cell miR-486-5p/miR-34c-5p in the progression of colorectal cancer. Clinical and Translational Oncology 2022; 25(3): 673 doi: 10.1007/s12094-022-02973-x
|
| 3 |
Amin Sepehr, Shadi Aghamohammad, Roya Ghanavati, Malihe Talebi, Mohammad Reza Pourshafie*, Mahdi Rohani. Role of Native Probiotic Lactobacillus Species via TGF-β Signaling Pathway Modulation in CRC. Iranian Biomedical Journal 2024; 28(4): 168 doi: 10.61186/ibj.4012
|
| 4 |
Xiaoshuang Li, Yanmin Wu, Tian Tian. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. International Journal of Molecular Sciences 2022; 23(22): 14436 doi: 10.3390/ijms232214436
|
